Preferences for PrEP modalities among gay, bisexual, and other men who have sex with men from Brazil, Mexico, and Peru: a cross-sectional study

被引:8
作者
Torres, Thiago S. [1 ]
Nascimento, Alessandro R. [2 ]
Coelho, Lara E. [2 ]
Konda, Kelika A. [3 ]
Vega-Ramirez, E. Hamid [4 ]
Elorreaga, Oliver A. [3 ]
Diaz-Sosa, Dulce [4 ]
Hoagland, Brenda [2 ]
Guanira, Juan V. [3 ]
Pimenta, Cristina [5 ]
Benedetti, Marcos [2 ]
Caceres, Carlos F. [3 ]
Veloso, Valdilea G. [2 ]
Grinsztejn, Beatriz [2 ]
机构
[1] Fundacao Oswaldo Cruz INI Fiocruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil,4365 Manguinhos, BR-21040360 Rio De Janeiro, Brazil
[2] Fundacao Oswaldo Cruz INI Fiocruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil
[3] Univ Peruana Cayetano Heredia, Lima, Peru
[4] Natl Inst Psychiat Ramon de la Fuente Muniz, Mexico City, Mexico
[5] Minist Hlth, Brasilia, Brazil
关键词
cabotegravir; HIV prevention; men who have sex with men; Latin America; PrEP; sexual and gender minorities; HIV PREEXPOSURE PROPHYLAXIS; TRANSGENDER WOMEN; CABOTEGRAVIR; PREVENTION; RISK;
D O I
10.1177/20499361231153548
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background:Pre-exposure prophylaxis (PrEP) scale-up is urgent to reduce new HIV cases among gay, bisexual, and other men who have sex with men (MSM) in Latin America. Different PrEP modalities may increase PrEP uptake and adherence, especially among young MSM. Objectives:To assess preferences for PrEP modalities among MSM from Brazil, Mexico, and Peru. Design:Cross-sectional web-based study (March-May 2018) targeting MSM through advertisements on Grindr, Hornet, and Facebook. We included MSM aged > 18 years and who reported HIV-negative status. Methods:We assessed preferences for PrEP modalities with the following question: 'Considering that all following PrEP modalities were available, which one would you prefer considering a scale from 1 to 3 (1 = most preferred): daily oral PrEP, event-driven PrEP (ED-PrEP), and long-acting injectable PrEP'. We assessed factors associated with each most preferred PrEP modality per country using multivariable logistic regression models. Results:A total of 19,457 MSM completed the questionnaire (Brazil: 58%; Mexico: 31%; Peru: 11%); median age was 28 years [interquartile range (IQR): 24-34]. Overall, injectable PrEP was the most preferred modality [42%; 95% confidence interval (CI): 41-43], followed by daily PrEP (35%; 95% CI: 34-35), and ED-PrEP (23%; 95% CI: 23-24). In multivariable models, preferring injectable PrEP was associated with PrEP awareness in all three countries, while PrEP eligibility only in Brazil. Preferring daily PrEP was associated with younger age and lower income in Brazil and Mexico, and lower education only in Brazil. The odds of preferring ED-PrEP were lower among MSM aware and eligible for PrEP in Brazil and Mexico. Conclusions:Long-acting injectable PrEP was the preferred PrEP modality among MSM in Brazil, Mexico, and Peru, especially those aware and eligible for PrEP. Public health interventions to increase PrEP modalities literacy and availability in Latin America are urgent especially among MSM of young age, lower income, and lower education.
引用
收藏
页数:11
相关论文
共 45 条
[1]   Complementary Recruitment Strategies to Reach Men Who Have Sex with Men and Transgender Women: The Experience of a Large Brazilian HIV Prevention Service [J].
Bezerra, Daniel R. B. ;
Jalil, Cristina M. ;
Jalil, Emilia M. ;
Coelho, Lara E. ;
Carvalheira, Eduardo ;
Freitas, Josias ;
Monteiro, Laylla ;
Santos, Toni ;
Souza, Cleo ;
Hoagland, Brenda ;
Veloso, Valdilea G. ;
Grinsztejn, Beatriz ;
Cardoso, Sandra W. ;
Torres, Thiago S. .
AIDS AND BEHAVIOR, 2022, 26 (08) :2643-2652
[2]  
Bezerra DRB., 2022, AIDS BEHAV, V6
[3]   Sexual Risk Behaviors and Acceptability of HIV Pre-Exposure Prophylaxis Among HIV-Negative Gay and Bisexual Men in Serodiscordant Relationships: A Mixed Methods Study [J].
Brooks, Ronald A. ;
Landovitz, Raphael J. ;
Kaplan, Rachel L. ;
Lieber, Eli ;
Lee, Sung-Jae ;
Barkley, Thomas W. .
AIDS PATIENT CARE AND STDS, 2012, 26 (02) :87-94
[4]   Impact of long-acting therapies on the global HIV epidemic [J].
Chandiwana, Nomathemba C. ;
Serenata, Celicia M. ;
Owen, Andrew ;
Rannard, Steve ;
Casas, Carmen Perez ;
Scott, Cherise ;
Hill, Andrew ;
Clayden, Polly ;
Flexner, Charles .
AIDS, 2021, 35 :S137-S143
[5]   Long-acting injectable cabotegravir for the prevention of HIV infection [J].
Clement, Meredith E. ;
Kofron, Ryan ;
Landovitz, Raphael J. .
CURRENT OPINION IN HIV AND AIDS, 2020, 15 (01) :19-26
[6]   The Prevalence of HIV Among Men Who Have Sex With Men (MSM) and Young MSM in Latin America and the Caribbean: A Systematic Review [J].
Coelho, Lara E. ;
Torres, Thiago S. ;
Veloso, Valdilea G. ;
Grinsztejn, Beatriz ;
Jalil, Emilia M. ;
Wilson, Erin C. ;
McFarland, Willi .
AIDS AND BEHAVIOR, 2021, 25 (10) :3223-3237
[7]   Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline [J].
Coelho, Lara Esteves ;
Torres, Thiago Silva ;
Veloso, Valdilea Goncalves ;
Landovitz, Raphael J. ;
Grinsztejn, Beatriz .
LANCET HIV, 2019, 6 (11) :E788-E799
[8]   Preferences for pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women at risk of HIV infection: a multicentre protocol for a discrete choice experiment in Brazil [J].
de Aguiar Pereira, Claudia Cristina ;
Torres, Thiago Silva ;
Luz, Paula Mendes ;
Hoagland, Brenda ;
Farias, Alessandro ;
Urbaez Brito, Jose David ;
Guimaraes Lacerda, Marcus Vinicius ;
Raenck da Silva, Daila Alena ;
Benedetti, Marcos ;
Pimenta, Maria Cristina ;
Grinsztejn, Beatriz ;
Veloso, Valdilea Goncalves .
BMJ OPEN, 2021, 11 (09)
[9]   Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial [J].
Delany-Moretlwe, Sinead ;
Hughes, James P. ;
Bock, Peter ;
Ouma, Samuel Gurrion ;
Hunidzarira, Portia ;
Kalonji, Dishiki ;
Kayange, Noel ;
Makhema, Joseph ;
Mandima, Patricia ;
Mathew, Carrie ;
Spooner, Elizabeth ;
Mpendo, Juliet ;
Mukwekwerere, Pamela ;
Mgodi, Nyaradzo ;
Ntege, Patricia Nahirya ;
Nair, Gonasagrie ;
Nakabiito, Clemensia ;
Nuwagaba-Biribonwoha, Harriet ;
Panchia, Ravindre ;
Singh, Nishanta ;
Siziba, Bekezela ;
Farrior, Jennifer ;
Rose, Scott ;
Anderson, Peter L. ;
Eshleman, Susan H. ;
Marzinke, Mark A. ;
Hendrix, Craig W. ;
Beigel-Orme, Stephanie ;
Hosek, Sybil ;
Tolley, Elizabeth ;
Sista, Nirupama ;
Adeyeye, Adeola ;
Rooney, James F. ;
Rinehart, Alex ;
Spreen, William R. ;
Smith, Kimberly ;
Hanscom, Brett ;
Cohen, Myron S. ;
Hosseinipour, Mina C. .
LANCET, 2022, 399 (10337) :1779-1789
[10]  
Elorreaga OA., 2022, LANCET REG HEALTH-AM, V2